Skip to main navigation
Skip to main content
Skip to Footer
Clinical Trials
Contact Us
Careers
Home
Our Motivation
Patient Stories
Bailey
Kendra
Sheri
Matty
Diseases & Conditions
PKU
CLN2 Disease
MPS VI
MPS IVA
MPS I
Patient & Community Support
Trees of Life
RARE Scholars
In the Hemophilia Community
Patient Advocacy
BioMarin RareConnections™
Grants & Donations
Resource Library
Patient Organizations
Professional Organizations
Our Science
Our Approach
Technical Expertise
Indication Expansion
Franchise Building
Our Scientists
Our Publications
Funding & Support
Independent Medical Education
Independent Research
Grants & Donations
Publication Data Request
Our Treatments
Our Products
PALYNZIQ
®
(pegvaliase-pqpz) Injection for PKU
Brineura
®
(cerliponase alfa) for CLN2 Disease
Vimizim
®
(elosulfase alfa) for Morquio A Syndrome (MPS IVA)
Kuvan
®
(sapropterin dihydrochloride) for PKU
Aldurazyme
®
(laronidase) for MPS I
Naglazyme
®
(galsulfase) for MPS VI
Our Pipeline
Valoctocogene Roxaparvovec for Severe Hemophilia A
Vosoritide for Achondroplasia
BMN 307 for Phenylketonuria (PKU)
BMN 331 for Hereditary Angioedema (HAE)
Our Company
About Us
Our History
Manufacturing Excellence
Message from Chairman and CEO
Diversity & Inclusion
Global Compliance & Ethics
Corporate Social Responsibility
Environmental Health, Safety and Sustainability (EHS&S)
Leadership Team
Jean-Jacques Bienaimé
Henry J. Fuchs, M.D.
Jeff Ajer
G. Eric Davis
C. Greg Guyer, Ph.D.
Brian R. Mueller
Lon Cardon, Ph.D.
Philip Lo Scalzo
Amy Wireman
Brinda Balakrishnan, M.D., Ph.D.
Board of Directors
Grants & Donations
Investors & Media
Press Releases
Events & Presentations
Corporate Governance
Financial Information
Analyst Coverage
Stock Information
Investor FAQs
Contact Us
Email Alerts
Search
our website
Close
Our Motivation
Patient Stories
Diseases & Conditions
Patient & Community Support
Trees of Life
RARE Scholars
In the Hemophilia Community
Patient Advocacy
BioMarin RareConnections™
Grants & Donations
Resources
Our Science
Our Approach
Technical Expertise
Indication Expansion
Franchise Building
Our Scientists
Our Publications
Funding & Support
Independent Medical Education
Independent Research
Grants & Donations
Publication Data Request
Our Treatments
Our Products
PALYNZIQ® (pegvaliase-pqpz) Injection for PKU
Kuvan® (sapropterin dihydrochloride) for PKU
Brineura® (cerliponase alfa) for CLN2 Disease
ALDURAZYME® (laronidase) for MPS I
Vimizim® (elosulfase alfa) for Morquio A Syndrome (MPS IVA)
Naglazyme® (galsulfase) for MPS VI
Our Pipeline
BMN 307 for Phenylketonuria (PKU)
BMN 331 for Hereditary Angioedema (HAE)
Valoctocogene Roxaparvovec for Severe Hemophilia A
Vosoritide for Achondroplasia
Compassionate Use Policy
Our Company
About Us
Corporate Social Responsibility
Environmental Health, Safety and Sustainability (EHS&S)
Leadership Team
Board of Directors
Grants & Donations
Investors & Media
Press Releases
Events & Presentations
Corporate Governance
Financial Information
Analyst Coverage
Stock Information
Investor FAQs
Contact Us
Email Alerts
Privacy Policy
Terms of Use
LinkedIn
Facebook
Site Map
Instagram
Supplier Information
YouTube
Glossary
© 2021 BioMarin. All rights reserved.
Report a Product Complaint
Contact Us
Locations
Global Medical Information
Report Adverse Event
Report a Product Complaint
Search
Get in touch with us.
*required fields
First Name
*
Last Name
*
Email Address
*
Profession
*
Please make a selection
Patient/Caregiver
Patient Advocacy Org
Healthcare Professional (HCP)
Student HCP
Health Agency
Insurer
Investor
Legal
Media
Publisher
Regulatory
Student
Wholesaler
Other
Please select a product
*
Please make a selection
PALYNZIQ
Brineura
Vimizim
Kuvan
Naglazyme
Aldurazyme
No Product Specified
Other
Other Product
*
Description/Complaint
*
Please enter the captcha below
Phone
This field is for validation purposes and should be left unchanged.
Home
›
Contact Us
›
Report a Product Complaint
